PTPN11 and myeloproliferative neoplasm: Remarkably, the introduction of Ptpn11 mutations into murine mesenchymal stem/progenitor cells (MPCs) and osteoprogenitors induced JMML-like MPN and donor-cell-derived MPN following stem cell transplantation as a consequence of excessive production of the pro-inflammatory chemokine CCL3 and the recruitment of monocytes that hyperactivate HSPCs by secreting interleukin 1β.